Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 3289750)

Published in Lab Invest on December 12, 2011

Authors

Chun-Liang Chen1, Xiaoyi Yu, Iyore O-A James, Hong-yi Zhang, Jingyuan Yang, Andrei Radulescu, Yu Zhou, Gail E Besner

Author Affiliations

1: Department of Pediatric Surgery, The Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH 43205, USA.

Articles citing this

Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis. J Biol Chem (2012) 1.31

Redefining the gut as the motor of critical illness. Trends Mol Med (2013) 1.15

Toll-like receptor 4-mediated endoplasmic reticulum stress in intestinal crypts induces necrotizing enterocolitis. J Biol Chem (2014) 0.98

Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy. Stem Cell Res Ther (2013) 0.91

Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg (2012) 0.91

Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury. J Pediatr Surg (2013) 0.89

Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. Am J Pathol (2014) 0.88

The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis. Am J Pathol (2014) 0.87

Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol (2014) 0.85

Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol (2014) 0.82

ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. Pediatr Res (2013) 0.82

Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects. Pathophysiology (2013) 0.81

Tissue underlying the intestinal epithelium elicits proliferation of intestinal stem cells following cytotoxic damage. Cell Tissue Res (2015) 0.80

Heparin-binding EGF-like growth factor (HB-EGF) promotes cell migration and adhesion via focal adhesion kinase. J Surg Res (2014) 0.80

HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury. J Pediatr Surg (2014) 0.79

Heparin-binding epidermal growth factor-like growth factor protects mesenchymal stem cells. J Surg Res (2012) 0.79

Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol (2016) 0.78

Heparin-binding EGF-like growth factor and enteric neural stem cell transplantation in the prevention of experimental necrotizing enterocolitis in mice. Pediatr Res (2015) 0.78

The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg (2013) 0.78

Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury. Surgery (2014) 0.76

Pathogenesis of NEC: Role of the innate and adaptive immune response. Semin Perinatol (2016) 0.75

Are EGF and TLR-4 crucial to understanding the link between milk and NEC? Mucosal Immunol (2015) 0.75

Heparin-binding EGF like growth factor promotes neuronal nitric oxide synthase expression and protects the enteric nervous system after necrotizing enterocolitis. Pediatr Res (2017) 0.75

Articles cited by this

Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature (2009) 19.18

Mammalian MAP kinase signalling cascades. Nature (2001) 18.89

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem (1994) 14.36

Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature (2008) 5.59

A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (1991) 5.14

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev (2011) 5.02

Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science (2005) 4.58

The intestinal stem cell. Genes Dev (2008) 4.21

Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology (2009) 4.16

Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci (2005) 3.97

Current view: intestinal stem cells and signaling. Gastroenterology (2008) 3.46

Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem (1995) 3.27

Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol (2009) 2.45

Methods for the isolation of intact epithelium from the mouse intestine. Anat Rec (1981) 2.33

Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology (2005) 2.23

EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors. Development (2009) 2.18

Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol (1995) 1.68

Stem cells as a potential future treatment of pediatric intestinal disorders. J Pediatr Surg (2008) 1.57

The stem cells of small intestinal crypts: where are they? Cell Prolif (2009) 1.55

Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology (2007) 1.55

Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol (2003) 1.51

Endotoxin inhibits intestinal epithelial restitution through activation of Rho-GTPase and increased focal adhesions. J Biol Chem (2004) 1.49

HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology (2005) 1.49

Treatment and prevention of necrotizing enterocolitis. Semin Neonatol (2003) 1.46

Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery (1975) 1.46

Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg (2006) 1.42

Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr (1990) 1.41

Mesenchymal stem cells. Ann Med (2005) 1.38

Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery (2007) 1.26

Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology (2009) 1.23

Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacol Ther (1999) 1.17

Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res (2007) 1.16

Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2007) 1.15

Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg (2003) 1.13

Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.05

Tissue engineering of small intestine--current status. Biomacromolecules (2006) 1.01

Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res (2009) 1.01

Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2006) 1.01

Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Pediatr Surg (2002) 0.97

EGF signaling activates proliferation and blocks apoptosis of mouse and human intestinal stem/progenitor cells in long-term monolayer cell culture. Lab Invest (2010) 0.95

Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes. Growth Factors (2010) 0.91

Macrophages secrete a heparin-binding inhibitor of endothelial cell growth. Microvasc Res (1991) 0.85

Isolation and characterization of the CD133+ precursors from the ventricular zone of human fetal brain by magnetic affinity cell sorting. Biotechnol Lett (2004) 0.84

Autoradiographic localization of (3H)-thymidine incorporation in the small intestinal epithelium of fetal sheep. J Pediatr Gastroenterol Nutr (1986) 0.82

Articles by these authors

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med (2008) 5.15

Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci (2010) 5.12

Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell (2009) 4.71

Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96

Hippocampal place cells acquire location-specific responses to the conditioned stimulus during auditory fear conditioning. Neuron (2003) 2.53

Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia. J Clin Oncol (2013) 2.44

Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell (2013) 2.43

Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer (2014) 2.24

Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A (2007) 2.04

SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase. Cell (2013) 1.97

FTRAC--a robust fluoroscope tracking fiducial. Med Phys (2005) 1.91

The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol Cell (2012) 1.83

Kinematic state estimation and motion planning for stochastic nonholonomic systems using the exponential map. Robotica (2008) 1.74

Molecular and cellular approaches to memory allocation in neural circuits. Science (2009) 1.70

Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett (2008) 1.62

CaMKII binding to GluN2B is critical during memory consolidation. EMBO J (2012) 1.62

Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. Mol Cell (2013) 1.56

Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis. J Pediatr (2007) 1.54

HB-EGF protects the lungs after intestinal ischemia/reperfusion injury. J Surg Res (2010) 1.51

HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology (2005) 1.49

Matching and reconstruction of brachytherapy seeds using the Hungarian algorithm (MARSHAL). Med Phys (2005) 1.49

Detection of herpes simplex virus type 1 in rheumatic valvular tissue. Chin Med J (Engl) (2005) 1.44

Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg (2006) 1.42

Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation (2012) 1.40

The impact of orthodontic treatment on the quality of life a systematic review. BMC Oral Health (2014) 1.40

HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab (2010) 1.39

A multiplex RNA-seq strategy to profile poly(A+) RNA: application to analysis of transcription response and 3' end formation. Genomics (2011) 1.37

Putting fear in its place: remapping of hippocampal place cells during fear conditioning. J Neurosci (2004) 1.36

mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons. Neuron (2013) 1.35

HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors (2007) 1.35

Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. Hum Genet (2010) 1.31

Quantifying the air pollutants emission reduction during the 2008 Olympic games in Beijing. Environ Sci Technol (2010) 1.30

Gating reaction mechanisms for NMDA receptor channels. J Neurosci (2005) 1.28

Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery (2007) 1.26

MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer (2013) 1.25

Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology (2009) 1.23

LRRC52 (leucine-rich-repeat-containing protein 52), a testis-specific auxiliary subunit of the alkalization-activated Slo3 channel. Proc Natl Acad Sci U S A (2011) 1.22

Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proc Natl Acad Sci U S A (2012) 1.18

Formation of bilayer bernal graphene: layer-by-layer epitaxy via chemical vapor deposition. Nano Lett (2011) 1.18

Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res (2007) 1.16

High-mobility group protein box-1 and its relevance to cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.16

Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology (2014) 1.16

Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2007) 1.15

Nuclear matrix factor hnRNP U/SAF-A exerts a global control of alternative splicing by regulating U2 snRNP maturation. Mol Cell (2012) 1.14

Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation (2013) 1.14

Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg (2003) 1.13

A cis element within flowering locus T mRNA determines its mobility and facilitates trafficking of heterologous viral RNA. J Virol (2009) 1.13

HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors (2008) 1.12

Ultrathin two-dimensional atomic crystals as stable interfacial layer for improvement of lithium metal anode. Nano Lett (2014) 1.12

Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg (2008) 1.11

Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice. J Pediatr Surg (2008) 1.11

Adding pyrrolysine to the Escherichia coli genetic code. FEBS Lett (2007) 1.09

Re: Impact of malocclusion on the quality of life of Saudi children. The Angle Orthodontist 2013(6) 1043-1048. Angle Orthod (2014) 1.09

Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum (2011) 1.08

Long-term outcomes of vaginoplasty with autologous buccal micromucosa. Obstet Gynecol (2014) 1.08

Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am J Pathol (2010) 1.08

Can we cut the incidence of necrotizing enterocolitis in half--today? Fetal Pediatr Pathol (2010) 1.08

Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Mol Immunol (2007) 1.07

Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg (2010) 1.07

Annealing-induced interfacial toughening using a molecular nanolayer. Nature (2007) 1.07

Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One (2012) 1.06

Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One (2010) 1.06

Measuring accurate body parameters of dressed humans with large-scale motion using a Kinect sensor. Sensors (Basel) (2013) 1.06

Isolation of scFvs to in vitro produced extracellular domains of EGFR family members. Cancer Biother Radiopharm (2005) 1.06

An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging (2010) 1.05

Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.05

Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery. Proc Natl Acad Sci U S A (2012) 1.05

Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice. Surgery (2009) 1.04

An infrared radiation study of the biophysical characteristics of traditional moxibustion. Complement Ther Med (2005) 1.04

Real-time photoacoustic and ultrasound dual-modality imaging system facilitated with graphics processing unit and code parallel optimization. J Biomed Opt (2013) 1.04

Amitriptyline-mediated cognitive enhancement in aged 3×Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity. PLoS One (2011) 1.04

Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal (2002) 1.04

Target-responsive "sweet" hydrogel with glucometer readout for portable and quantitative detection of non-glucose targets. J Am Chem Soc (2013) 1.04

Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia/reperfusion injury. J Invest Surg (2003) 1.02

Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2006) 1.01

Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res (2009) 1.01

Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep (2009) 1.01

Characteristic and in vitro bioactivity of a microarc-oxidized TiO(2)-based coating after chemical treatment. Acta Biomater (2007) 1.01

A limited access compartment between the pore domain and cytosolic domain of the BK channel. J Neurosci (2006) 1.00

eIF2B promotes eIF5 dissociation from eIF2*GDP to facilitate guanine nucleotide exchange for translation initiation. Genes Dev (2013) 0.99

Oral cancer overexpressed 1 (ORAOV1) regulates cell cycle and apoptosis in cervical cancer HeLa cells. Mol Cancer (2010) 0.99

Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil (2002) 0.99

MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. Mol Cell Biochem (2013) 0.99

Controlled synthesis of spinel ZnFe2O4 decorated ZnO heterostructures as peroxidase mimetics for enhanced colorimetric biosensing. Chem Commun (Camb) (2013) 0.99

Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy. Cancer Treat Rev (2012) 0.98

Nasal-type NK/T-cell lymphoma with palatal ulcer as the earliest clinical manifestation: a case report with literature review. Pathol Oncol Res (2009) 0.98

Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Pediatr Surg (2002) 0.97

Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury. Semin Pediatr Surg (2004) 0.97

Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor. J Immunol (2003) 0.97

Total tubeless versus standard percutaneous nephrolithotomy: a meta-analysis. J Endourol (2013) 0.96

Photochemical chlorination of graphene. ACS Nano (2011) 0.96

Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol (2014) 0.96

Estimation of chlorophyll-a concentration in Turbid Lake using spectral smoothing and derivative analysis. Int J Environ Res Public Health (2013) 0.96